Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 114

    1.

    Zidovudine: five years later.

    McLeod GX, Hammer SM.

    Ann Intern Med. 1992 Sep 15;117(6):487-501. Review.PMID: 1503352 [PubMed - indexed for MEDLINE]Related articles

    2.

    Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

    Wilde MI, Langtry HD.

    Drugs. 1993 Sep;46(3):515-78. Review.PMID: 7693435 [PubMed - indexed for MEDLINE]Related articles

    3.

    AIDS: Part II.

    Kessler HA, Bick JA, Pottage JC Jr, Benson CA.

    Dis Mon. 1992 Oct;38(10):691-764. Review.PMID: 1396036 [PubMed - indexed for MEDLINE]Related articles

    4.

    Zidovudine (Retrovir) update.

    Rachlis AR.

    CMAJ. 1990 Dec 1;143(11):1177-85. Review.PMID: 2224694 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection.

    Adkins JC, Peters DH, Faulds D.

    Drugs. 1997 Jun;53(6):1054-80. Review.PMID: 9179531 [PubMed - indexed for MEDLINE]Related articles

    6.

    Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues.

    Kamali F.

    Clin Investig. 1993 May;71(5):392-405. Review.PMID: 7685214 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lopinavir/ritonavir: a review of its use in the management of HIV infection.

    Cvetkovic RS, Goa KL.

    Drugs. 2003;63(8):769-802. Review.PMID: 12662125 [PubMed - indexed for MEDLINE]Related articles

    8.

    Current perspectives on antiretroviral therapy.

    Fletcher CV.

    Pharmacotherapy. 1993 Nov-Dec;13(6):627-33. Review.PMID: 7508101 [PubMed - indexed for MEDLINE]Related articles

    10.

    Didanosine: an updated review of its use in HIV infection.

    Perry CM, Noble S.

    Drugs. 1999 Dec;58(6):1099-135. Review.PMID: 10651392 [PubMed - indexed for MEDLINE]Related articles

    11.

    Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.

    Spruance SL, Pavia AT, Mellors JW, Murphy R, Gathe J Jr, Stool E, Jemsek JG, Dellamonica P, Cross A, Dunkle L.

    Ann Intern Med. 1997 Mar 1;126(5):355-63.PMID: 9054279 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

    Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD, et al.

    Ann Intern Med. 1990 May 15;112(10):727-37.PMID: 1970466 [PubMed - indexed for MEDLINE]Related articles

    13.

    Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study Group.

    Montaner JS, Schechter MT, Rachlis A, Gill J, Beaulieu R, Tsoukas C, Raboud J, Cameron B, Salomon H, Dunkle L, Smaldone L, Wainberg MA.

    Ann Intern Med. 1995 Oct 15;123(8):561-71.PMID: 7677296 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.

    Hammer SM, Katzenstein DA, Hughes MD, Gundacker H, Schooley RT, Haubrich RH, Henry WK, Lederman MM, Phair JP, Niu M, Hirsch MS, Merigan TC.

    N Engl J Med. 1996 Oct 10;335(15):1081-90.PMID: 8813038 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Randomized study of didanosine monotherapy and combination therapy with zidovudine in hemophilic and nonhemophilic subjects with asymptomatic human immunodeficiency virus-1 infection. AIDS Clinical Trial Groups.

    Ragni MV, Amato DA, LoFaro ML, DeGruttola V, Van Der Horst C, Eyster ME, Kessler CM, Gjerset GF, Ho M, Parenti DM, et al.

    Blood. 1995 May 1;85(9):2337-46.PMID: 7727768 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Salvage therapy for zidovudine-intolerant HIV-infected patients with alternating and intermittent regimens of zidovudine and dideoxycytidine.

    Bozzette SA, Richman DD.

    Am J Med. 1990 May 21;88(5B):24S-26S. Review.PMID: 2159706 [PubMed - indexed for MEDLINE]Related articles

    17.

    Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

    Katlama C, Ingrand D, Loveday C, Clumeck N, Mallolas J, Staszewski S, Johnson M, Hill AM, Pearce G, McDade H.

    JAMA. 1996 Jul 10;276(2):118-25.PMID: 8656503 [PubMed - indexed for MEDLINE]Related articles

    18.

    A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia.

    Phanuphak P, Grayson ML, Sirivichayakul S, Suwanagool S, Ruxrungtham K, Hanvanich M, Ratanasuwan W, Ubolyam S, Hughes MD, Wanke CA, Hammer SM.

    Aust N Z J Med. 2000 Feb;30(1):11-20.PMID: 10800872 [PubMed - indexed for MEDLINE]Related articles

    20.

    Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.

    D'Aquila RT, Hughes MD, Johnson VA, Fischl MA, Sommadossi JP, Liou SH, Timpone J, Myers M, Basgoz N, Niu M, Hirsch MS.

    Ann Intern Med. 1996 Jun 15;124(12):1019-30.PMID: 8633815 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data